Intel has not had a week like this in a long time. Shares of the chipmaker surged roughly 4% on Tuesday, April 8, then climbed again on Wednesday after the company confirmed it would serve as a manufacturing partner in Elon Musk’s Terafab project, a plan to build what Musk has called the world’s largest chip factory. By midweek, Intel had reached a five-year high near the $32 range, and its year-to-date gain had blown past 58% from a starting price around $20 at the open of 2026, according to Zacks Investment Research.
The two-day move landed on the question that has defined Intel’s turnaround story: whether its expensive, risky pivot to contract chip manufacturing can actually pay off.
What the partnership involves
Intel disclosed that it is joining a consortium alongside SpaceX, xAI, and Tesla to support the Terafab initiative. Musk has described the project in prior public statements as essential infrastructure for the next generation of AI development, and Business Insider reported that he has framed the planned facility as far exceeding the scale of any single existing fab.
Intel’s role centers on its foundry operations. Under CEO Lip-Bu Tan, who took the helm in March 2025, the company has accelerated its IDM 2.0 strategy: transforming Intel from a chipmaker that primarily manufactures its own designs into a contract manufacturer that also builds chips for outside customers. Joining the Terafab consortium would hand Intel a potential customer pipeline spanning autonomous vehicles through Tesla, satellite communications through SpaceX, and large-scale AI model training through xAI. That breadth matters because Intel’s foundry business has so far announced only a handful of early external customers, and diversifying that base is central to the strategy’s viability.
TradingKey noted that Intel’s stock had already been climbing on broader optimism around the company’s AI chip ambitions before the Terafab news broke. The announcement poured fuel on a rally that was already building momentum.
Tesla shares, by contrast, slipped about 2% on Tuesday even as Intel surged, according to Investopedia. The divergence is telling. Wall Street appears to view the deal as more immediately valuable to Intel’s foundry ambitions than to Musk’s existing public companies. For Tesla shareholders, Terafab may look like yet another capital-hungry Musk venture competing for management bandwidth.
What is still missing
The rally has outrun the paperwork. As of mid-April 2026, no official Intel press release, SEC filing, or material definitive agreement related to Terafab has appeared on the company’s investor relations page or in the EDGAR database. That creates an awkward gap: investors are pricing in a partnership whose financial terms, capital commitments, revenue-sharing structure, and construction timeline remain formally undisclosed. The word “confirmed” in early reporting appears to trace to executive statements and sourced accounts rather than to binding corporate filings.
The technical ambitions are similarly undefined. Some reports have referenced a “1 terawatt” target for the facility, but that figure has not been clearly explained. Terawatt is a unit of electrical power, not computing performance, and whether Musk is describing the factory’s power draw, some novel measure of aggregate compute output, or simply using the term as branding is an open question. No engineering plans, environmental impact assessments, or site selection details have surfaced publicly.
The scale Musk has described would be extraordinary. For comparison, TSMC’s Arizona fab complex, currently the largest advanced semiconductor project under construction in the United States, carries an estimated price tag exceeding $40 billion, a figure that has been revised upward multiple times. A facility that reportedly “dwarfs existing fabs” would demand comparable or greater capital, reliable access to water and electricity at industrial scale, and years of construction before producing a single chip.
Then there is the financial backdrop inside Intel itself. The company’s foundry division reported operating losses exceeding $7 billion in fiscal 2024, underscoring how far the unit remains from profitability. Intel has secured up to $7.86 billion in CHIPS Act funding to support its domestic manufacturing expansion, but committing to a project on the scale Musk envisions would test the company’s balance sheet and its ability to execute on multiple fronts simultaneously.
Regulatory questions also loom. A manufacturing partnership linking Intel with Tesla, SpaceX, and xAI could draw antitrust scrutiny, particularly given the concentration of AI compute capacity the facility would represent. No reporting has surfaced pre-merger notifications or government reviews, which could mean the deal’s structure falls below review thresholds or that those processes have not yet begun.
What investors should watch
Intel reaching a five-year peak near the $32 range is a concrete market event, and the 58%-plus year-to-date gain reported by Zacks reflects how aggressively investors are betting on the foundry strategy. But the distance between that enthusiasm and the confirmed details remains wide. Every source reporting on Terafab’s technical scope traces back to Musk’s own statements or analyst commentary rather than to corporate filings or construction permits.
The competitive picture sharpens the stakes. Intel is not building its foundry business unopposed. TSMC remains the dominant contract chipmaker globally, manufacturing advanced processors for Apple, Nvidia, AMD, and dozens of other companies. Samsung is expanding its foundry capacity as well. For Intel’s Terafab involvement to meaningfully shift the balance, the project would need to reach production at leading-edge process nodes, something Intel has struggled with in recent years despite billions in investment.
For readers holding Intel shares or weighing a position, the practical next step is straightforward: watch Intel’s investor relations page and SEC filings for any 8-K or definitive agreement that formalizes the partnership. Intel’s next quarterly earnings call will be a critical moment, as analysts are certain to press management on the deal’s financial impact, timeline, and capital requirements. Until those details surface, the market is trading on the signal value of the announcement, not on binding terms.
The run-up also means a significant amount of optimism is already embedded in the share price. If execution stumbles or the Terafab timeline stretches further than investors expect, the stock could return gains quickly. The gap between a headline partnership and an operational semiconductor fab is measured in years and tens of billions of dollars. Intel’s bet on Terafab may ultimately prove transformative, but the public evidence to confirm that outcome has not arrived yet.
